Mirada Life Sciences
Aki Yoneda Kau is a seasoned professional in the field of molecular microbiology with extensive experience in various leadership roles. Currently serving as a Senior Consultant at Mirada Life Sciences since January 2022, Aki has previously held positions such as Director of Research and Development at resistanceBio and Chief Scientific Officer at Viosera Therapeutics. Aki's background includes a significant tenure at Washington University in St. Louis, where contributions spanned roles as a Staff Scientist and Postdoctoral Research Associate, focusing on engineering microorganisms and biochemical characterization. Aki obtained a Ph.D. in Molecular Microbiology from Washington University in St. Louis and a BS in Biological Sciences from Japan Women's University.
This person is not in any teams
Mirada Life Sciences
Combining scientific expertise with a deep understanding of healthcare trends, the access landscape, & clinical breakthroughs to support medical affairs professionals to deliver insightful solutions. The Mirada Life Sciences team has over 15 years of experience working in the US and Global healthcare systems, making us uniquely qualified to tackle any project. We use a hands-on approach to identify and address internal and external education gaps. Our curiosity-driven collaboration cultivates lasting relationships, allowing us to understand the broader project implications and develop strategic engagements to solve day-to-day challenges. Visit our website to learn more about the Mirada Impact.